$ 15.4 billion
Completed
1/4/2015
Kurt Stumpo - Journalist
Canada
United States
Acquisition finance
Private acquisition
Capital markets : High yield
M&A
United States
Pharmaceuticals and life sciences
Party: Salix Pharmaceuticals (Target)
Lawyers: Christopher Cox, Greg Patti
Party: Deutsche Bank Securities (Joint bookrunner)
Party: HSBC (Joint bookrunner)
Party: Mitsubishi UFJ Financial Group (Joint bookrunner)
Party: DNB Markets (Joint bookrunner)
Party: SunTrust Robinson Humphrey (Joint bookrunner)
Party: Barclays (Joint bookrunner)
Party: Morgan Stanley (Joint bookrunner)
Party: RBC Capital Markets (Joint bookrunner)
Party: Citigroup (Joint bookrunner)
Lawyers: John Tripodoro, Noah Newitz, Timothy Howell, William Hartnett
Party: Valeant Pharmaceuticals (Issuer)
Lawyers: Michael Zeidel, Ryan Dzierniejko, Stephen Arcano
Party: Valeant Pharmaceuticals (Acquirer)
Lawyers: Alan Sinsheimer, Alison Ressler, Eric Krautheimer, Sarah Payne
Party: Centerview Partners (Financial adviser)
Lawyers: Laura Delanoy, Steven Seidman